Compare WDS & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WDS | CNC |
|---|---|---|
| Founded | 1954 | 1984 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.3B | 18.7B |
| IPO Year | N/A | 2001 |
| Metric | WDS | CNC |
|---|---|---|
| Price | $15.20 | $39.92 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 17 |
| Target Price | N/A | ★ $40.06 |
| AVG Volume (30 Days) | 879.0K | ★ 7.2M |
| Earning Date | 08-18-2025 | 02-03-2026 |
| Dividend Yield | ★ 6.85% | N/A |
| EPS Growth | ★ 58.72 | N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | $13,781,000,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | N/A | $32.54 |
| Revenue Next Year | N/A | $0.19 |
| P/E Ratio | $9.80 | ★ N/A |
| Revenue Growth | 9.53 | ★ 14.57 |
| 52 Week Low | $11.26 | $25.08 |
| 52 Week High | $17.70 | $66.81 |
| Indicator | WDS | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 36.76 | 58.86 |
| Support Level | $14.57 | $38.02 |
| Resistance Level | $16.98 | $39.91 |
| Average True Range (ATR) | 0.27 | 1.26 |
| MACD | -0.19 | -0.06 |
| Stochastic Oscillator | 27.44 | 60.80 |
Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.